perhexiline and debrisoquin

perhexiline has been researched along with debrisoquin in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (70.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	1 (10.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Maurer, R; Satz, N; Spycher, MA; Streuli, R; Täuber, M	1
Park, BK	1
Eichelbaum, M	2
Idle, JR; Lockhart, JD; Oates, NS; Shah, RR; Smith, RL	2
Morgan, MY; Oates, NS; Reshef, R; Shah, RR; Sherlock, S; Smith, RL	1
Braunschweig, S; Dick, B; Küpfer, A; Molnàr, J; Preisig, R	1

Reviews

2 review(s) available for perhexiline and debrisoquin

Article	Year
Polymorphic oxidation of debrisoquine and sparteine. Progress in clinical and biological research, 1986, Volume: 214 Topics: Chromosome Mapping; Cytochrome P-450 Enzyme System; Debrisoquin; Genetic Linkage; Humans; Isoenzymes; Isoquinolines; Kinetics; Liver; Molecular Conformation; Oxidation-Reduction; Perhexiline; Phenotype; Polymorphism, Genetic; Sparteine	1986
[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications]. Der Internist, 1983, Volume: 24, Issue:3 Topics: Adrenergic beta-Antagonists; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Hydroxylation; Mephenytoin; Oxidation-Reduction; Perhexiline; Pharmaceutical Preparations; Phenacetin; Phenformin; Phenotype; Phenytoin; Polymorphism, Genetic; Receptors, Drug; Sparteine	1983

Article

Year

Polymorphic oxidation of debrisoquine and sparteine.

Progress in clinical and biological research, 1986, Volume: 214

Topics: Chromosome Mapping; Cytochrome P-450 Enzyme System; Debrisoquin; Genetic Linkage; Humans; Isoenzymes; Isoquinolines; Kinetics; Liver; Molecular Conformation; Oxidation-Reduction; Perhexiline; Phenotype; Polymorphism, Genetic; Sparteine

1986

[Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].

Der Internist, 1983, Volume: 24, Issue:3

Topics: Adrenergic beta-Antagonists; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Hydroxylation; Mephenytoin; Oxidation-Reduction; Perhexiline; Pharmaceutical Preparations; Phenacetin; Phenformin; Phenotype; Phenytoin; Polymorphism, Genetic; Receptors, Drug; Sparteine

1983

Other Studies

8 other study(ies) available for perhexiline and debrisoquin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Perhexiline maleate-induced hepatitis. Hepato-gastroenterology, 1991, Volume: 38, Issue:4 Topics: Angina Pectoris; Biopsy; Chemical and Drug Induced Liver Injury; Debrisoquin; Humans; Liver; Male; Microscopy, Electron; Middle Aged; Perhexiline; Time Factors	1991
Metabolic basis of adverse drug reactions. Journal of the Royal College of Physicians of London, 1986, Volume: 20, Issue:3 Topics: Acetaminophen; Acetylation; Adrenergic beta-Antagonists; Adult; Age Factors; Child; Debrisoquin; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Enzyme Inhibitors; Humans; Perhexiline; Pharmaceutical Preparations; Phenacetin; Phenformin; Phenotype; Polymorphism, Genetic; Succinylcholine	1986
Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. British medical journal (Clinical research ed.), 1982, Jan-30, Volume: 284, Issue:6312 Topics: Adult; Aged; Alcohol Drinking; Angina Pectoris; Debrisoquin; Female; Humans; Isoquinolines; Liver Function Tests; Male; Middle Aged; Oxidation-Reduction; Perhexiline; Peripheral Nervous System Diseases; Piperidines; Smoking	1982
Prediction of subclinical perhexiline neuropathy in a patient with inborn error of debrisoquine hydroxylation. American heart journal, 1983, Volume: 105, Issue:1 Topics: Angina Pectoris; Debrisoquin; Electromyography; Humans; Hydroxylation; Isoquinolines; Male; Middle Aged; Perhexiline; Peripheral Nervous System Diseases; Phenotype; Piperidines; Polymorphism, Genetic	1983
Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut, 1984, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Angina Pectoris; Chemical and Drug Induced Liver Injury; Chronic Disease; Debrisoquin; Female; Humans; Isoquinolines; Liver Diseases; Male; Middle Aged; Oxidation-Reduction; Perhexiline; Phenotype	1984
[Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]. Schweizerische medizinische Wochenschrift, 1982, Jul-24, Volume: 112, Issue:30 Topics: Adolescent; Adult; Aged; Debrisoquin; Female; Homozygote; Humans; Hydroxylation; Isoquinolines; Male; Metabolism, Inborn Errors; Middle Aged; Nervous System Diseases; Perhexiline; Phenotype; Population Surveillance; Random Allocation; Switzerland	1982